People with BRCA1 and BRCA2 mutations are recommended to have a transvaginal ultrasound 1-2 times per year. Screening with CA-125 is also recommended. Prophylactic salpingo-oophorectomy (removal of the ovaries and Fallopian tubes to prevent<unk>  is recommended at age 35-40 for people with BRCA1 mutations and at age 40-45 for people with BRCA2 mutations.
Hereditary breast–ovarian cancer syndrome
Estrogen insensitivity syndrome
Aromatase excess syndrome
Hereditary leiomyomatosis and renal cell cancer syndrome
Hereditary lobular breast cancer
Multiple endocrine neoplasia
Angelman syndrome
Multiple endocrine neoplasia type 1